ASTRAZENECA GLUCOSE 5% 5g/100mL injection BP vial

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

glucose, Quantity: 50 mg/mL

Available from:

Phebra Pty Ltd

INN (International Name):

glucose

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: sodium bicarbonate; water for injections

Administration route:

Intravenous

Units in package:

100mL x 1, 100mL x 5

Prescription type:

Not scheduled. Not considered by committee

Therapeutic indications:

This product accepted for registration/listing as 'currently supplied' at the time of commencement of the Act. Indications held in ARTG paper records. (Old code) INDICATIONS AS AT 4 APRIL 2003: Glucose Injection BP 5% is used in the treatment of carbohydrate and fluid depletion. Glucose is the preferred source of carbohydrate in parenteral nutrition regimes, and is used in the treatment of dehydration due to acute diarrhoeal disease. Glucose Injection BP 5% may also be used to treat hypoglycaemia.

Product summary:

Visual Identification: Clear colourless particle-free solution; Container Type: Vial; Container Material: Glass; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

1991-08-13